TPDB14828

Evidence 1 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 10 µg/mL

Target

Target Organism Staphylococcus aureus ATCC 6535

Source & Reference

Database Source dbAMP

Other

Source Activity Label	Source Definition
Antibacterial	dbAMP classified as Antibacterial under the Anti-bacterial function class.

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria

Evidence 2 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 15 µg/mL

Target

Target Organism S. saprophyticus

Source & Reference

Database Source dbAMP

Other

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml)

Evidence 3 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 10 µg/mL

Target

Target Organism B. subtilis CCT 2471

Source & Reference

Database Source dbAMP

Other

Evidence Text

ainst Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml

Evidence 4 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 2.5 µg/mL

Target

Target Organism Escherichia coli CCT 1371

Source & Reference

Database Source dbAMP

Other

Evidence Text

S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aerugi

Evidence 5 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 10 µg/mL

Target

Target Organism Enterobacter cloacae ACCT 23355

Source & Reference

Database Source dbAMP

Other

Evidence Text

B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yea

Evidence 6 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 10 µg/mL

Target

Target Organism Klebsiella pneumoniae ACCT 13883

Source & Reference

Database Source dbAMP

Other

Evidence Text

nd Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also i

Evidence 7 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 10 µg/mL

Target

Target Organism P. aeruginsa ACCT 27853

Source & Reference

Database Source dbAMP

Other

Evidence Text

.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml

Evidence 8 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 2.5 µg/mL

Target

Target Organism Candida albicans

Source & Reference

Database Source dbAMP

Other

Evidence Text

. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 2

Evidence 9 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 12.5 µg/mL

Target

Target Organism L. monocytogenes

Source & Reference

Database Source dbAMP

Other

Evidence Text

uginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 3

Evidence 10 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 32 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source dbAMP

Other

Evidence Text

nes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) (

Evidence 11 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 16-64 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source dbAMP

Other

Evidence Text

lity using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofi

Evidence 12 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antibacterial

Activity Measurement 128 µM

Target

Target Organism K.pneumoniae 106 or 242

Source & Reference

Database Source dbAMP

Other

Evidence Text

n-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofilms:K. pneumoniae (24 h), dose-depende

Evidence 13 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 10 µg/mL

Target

Target Organism Staphylococcus aureus ATCC 6535

Source & Reference

Database Source dbAMP CAFPdb

Other

Source Activity Label	Source Definition
Antifungal	dbAMP classified under the Anti-fungal function class.

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria

Evidence 14 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 15 µg/mL

Target

Target Organism S. saprophyticus

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml)

Evidence 15 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 10 µg/mL

Target

Target Organism B. subtilis CCT 2471

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

ainst Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml

Evidence 16 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 2.5 µg/mL

Target

Target Organism Escherichia coli CCT 1371

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aerugi

Evidence 17 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 10 µg/mL

Target

Target Organism Enterobacter cloacae ACCT 23355

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yea

Evidence 18 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 10 µg/mL

Target

Target Organism Klebsiella pneumoniae ACCT 13883

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

nd Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also i

Evidence 19 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 10 µg/mL

Target

Target Organism P. aeruginsa ACCT 27853

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml

Evidence 20 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 2.5 µg/mL

Target

Target Organism Candida albicans

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 2

Evidence 21 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 12.5 µg/mL

Target

Target Organism L. monocytogenes

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

uginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 3

Evidence 22 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 32 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

nes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) (

Evidence 23 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 16-64 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

lity using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofi

Evidence 24 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antifungal

Activity Measurement 128 µM

Target

Target Organism K.pneumoniae 106 or 242

Source & Reference

Database Source dbAMP CAFPdb

Other

Evidence Text

n-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofilms:K. pneumoniae (24 h), dose-depende

Evidence 25 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 10 µg/mL

Target

Target Organism Staphylococcus aureus ATCC 6535

Source & Reference

Database Source NA

Other

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria

Evidence 26 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 15 µg/mL

Target

Target Organism S. saprophyticus

Source & Reference

Database Source NA

Other

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml)

Evidence 27 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 10 µg/mL

Target

Target Organism B. subtilis CCT 2471

Source & Reference

Database Source NA

Other

Evidence Text

ainst Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml

Evidence 28 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 2.5 µg/mL

Target

Target Organism Escherichia coli CCT 1371

Source & Reference

Database Source NA

Other

Evidence Text

S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aerugi

Evidence 29 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 10 µg/mL

Target

Target Organism Enterobacter cloacae ACCT 23355

Source & Reference

Database Source NA

Other

Evidence Text

B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yea

Evidence 30 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 10 µg/mL

Target

Target Organism Klebsiella pneumoniae ACCT 13883

Source & Reference

Database Source NA

Other

Evidence Text

nd Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also i

Evidence 31 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 10 µg/mL

Target

Target Organism P. aeruginsa ACCT 27853

Source & Reference

Database Source NA

Other

Evidence Text

.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml

Evidence 32 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 2.5 µg/mL

Target

Target Organism Candida albicans

Source & Reference

Database Source NA

Other

Evidence Text

. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 2

Evidence 33 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 12.5 µg/mL

Target

Target Organism L. monocytogenes

Source & Reference

Database Source NA

Other

Evidence Text

uginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 3

Evidence 34 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 32 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source NA

Other

Evidence Text

nes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) (

Evidence 35 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 16-64 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source NA

Other

Evidence Text

lity using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofi

Evidence 36 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiparasitic

Activity Measurement 128 µM

Target

Target Organism K.pneumoniae 106 or 242

Source & Reference

Database Source NA

Other

Evidence Text

n-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofilms:K. pneumoniae (24 h), dose-depende

Evidence 37 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 10 µg/mL

Target

Target Organism Staphylococcus aureus ATCC 6535

Source & Reference

Database Source NA

Other

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria

Evidence 38 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 15 µg/mL

Target

Target Organism S. saprophyticus

Source & Reference

Database Source NA

Other

Evidence Text

Active against Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml)

Evidence 39 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 10 µg/mL

Target

Target Organism B. subtilis CCT 2471

Source & Reference

Database Source NA

Other

Evidence Text

ainst Gram+ bacteria S. aureus ATCC 6535 (MIC 10 ug/ml), S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml

Evidence 40 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 2.5 µg/mL

Target

Target Organism Escherichia coli CCT 1371

Source & Reference

Database Source NA

Other

Evidence Text

S. saprophyticus (MIC 15 ug/ml), B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aerugi

Evidence 41 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 10 µg/mL

Target

Target Organism Enterobacter cloacae ACCT 23355

Source & Reference

Database Source NA

Other

Evidence Text

B. subtilis CCT 2471 (MIC 10 ug/ml), and Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yea

Evidence 42 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 10 µg/mL

Target

Target Organism Klebsiella pneumoniae ACCT 13883

Source & Reference

Database Source NA

Other

Evidence Text

nd Gram- bacteria E. coli CCT 1371 (MIC 2.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also i

Evidence 43 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 10 µg/mL

Target

Target Organism P. aeruginsa ACCT 27853

Source & Reference

Database Source NA

Other

Evidence Text

.5 ug/ml), E. cloacae ACCT 23355 (MIC 10 ug/ml), K. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml

Evidence 44 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 2.5 µg/mL

Target

Target Organism Candida albicans

Source & Reference

Database Source NA

Other

Evidence Text

. pneumoniae ACCT 13883 (MIC 10 ug/ml), P. aeruginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 2

Evidence 45 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 12.5 µg/mL

Target

Target Organism L. monocytogenes

Source & Reference

Database Source NA

Other

Evidence Text

uginsa ACCT 27853 (MIC 10 ug/ml), and yeast C. albicans (MIC 2.5 ug/ml). It also inhibits L. monocytogenes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 3

Evidence 46 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 32 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source NA

Other

Evidence Text

nes (MIC 12.5 ug/ml). Antimicrobial susceptibility using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) (

Evidence 47 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 16-64 µM

Target

Target Organism Klebsiella pneumoniae

Source & Reference

Database Source NA

Other

Evidence Text

lity using 20 strains: colistin-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofi

Evidence 48 Activity

Activity

Activity Endpoint MIC

Detail Source Activity Antiviral

Activity Measurement 128 µM

Target

Target Organism K.pneumoniae 106 or 242

Source & Reference

Database Source NA

Other

Evidence Text

n-susceptible K. pneumoniae (MIC 32 uM), colistin-resistant K. pneumoniae (MIC 16-64 uM), K.pneumoniae 106 or 242 (MIC 128 uM) ( Lima et al., 2025 ). Antibiofilm: disrupted biofilms:K. pneumoniae (24 h), dose-depende

Evidence 49 Activity

Activity

Activity Endpoint 0% Hemolysis

Detail Source Activity Toxicity

Activity Measurement 256 µM

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

0% Hemolysis | 256 | µM | target cell: Mouse erythrocytes

Target

Target Cell Mouse erythrocytes

Source & Reference

Database Source NA

Source Database DBAASP

Reference

The effect of halogenation on the antimicrobial activity, antibiofilm activity, cytotoxicity and proteolytic stability of the antimicrobial peptide Jelleine-I. | Peptides | 2018

Evidence 50 Activity

Activity

Activity Endpoint 10% Killing

Detail Source Activity Toxicity

Activity Measurement 256 µM

Toxicity Type Cytotoxic

Toxicity Raw

10% Killing | 256 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Target Cell Mouse fibroblasts NIH 3T3

Source & Reference

Database Source NA

Source Database DBAASP

Reference

The effect of halogenation on the antimicrobial activity, antibiofilm activity, cytotoxicity and proteolytic stability of the antimicrobial peptide Jelleine-I. | Peptides | 2018

Evidence 51 Activity

Activity

Activity Endpoint <5% Hemolysis

Detail Source Activity Toxicity

Activity Measurement <256 µM

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

<5% Hemolysis | <256 | µM | target cell: Human erythrocytes

Target

Target Cell Human erythrocytes

Source & Reference

Database Source NA

Source Database DBAASP

Reference

An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P. aeruginosa and negligible toxicity in vitro and in vivo. | Eur J Med Chem | 2021

Evidence 52 Activity

Activity

Activity Endpoint <15% Killing

Detail Source Activity Toxicity

Activity Measurement 256 µM

Toxicity Type Cytotoxic

Toxicity Raw

<15% Killing | 256 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Target Cell Mouse fibroblasts NIH 3T3

Source & Reference

Database Source NA

Source Database DBAASP

Reference

An optimized analog of antimicrobial peptide Jelleine-1 shows enhanced antimicrobial activity against multidrug resistant P. aeruginosa and negligible toxicity in vitro and in vivo. | Eur J Med Chem | 2021